Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
04/2010
04/27/2010US7705015 Substituted pyrroline kinase inhibitors
04/27/2010US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer
04/27/2010US7704506 Fcε-PE chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same
04/27/2010US7704497 Molecules with extended half-lives, compositions and uses thereof
04/27/2010CA2462939C Novel derivatives of isoquinoline, process for their preparation and pharmaceutical compositions containing them
04/27/2010CA2449180C Viral polymerase inhibitors
04/27/2010CA2437524C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
04/27/2010CA2422378C Pyrazole compounds useful as protein kinase inhibitors
04/27/2010CA2413857C Pd-l2 molecules: pd-1 ligands and uses therefor
04/27/2010CA2338968C Glucocorticoid-selective agents
04/27/2010CA2323776C Cytokine receptor common gamma chain like
04/27/2010CA2321951C Dietary control of arachidonic acid metabolism
04/27/2010CA2321926C Use of rhamnolipids in a composition for the treatment of signs of aging
04/27/2010CA2297998C Aqueous solution for use in the treatment of degenerative or autoimmune diseases and as an immunomodulatory agent
04/27/2010CA2293692C Methods and reagents for vaccination which generate a cd8 t cell immune response
04/27/2010CA2222129C A method for producing influenza hemagglutinin multivalent vaccines
04/27/2010CA2179909C Ligand that binds fas antigen
04/22/2010WO2010045431A2 Dry powder formulations, vaccines and methods
04/22/2010WO2010045276A2 Azabenzimidazolones
04/22/2010WO2010045199A2 Method of modulating ship activity
04/22/2010WO2010044691A1 Immunosuppressive peptide
04/22/2010WO2010043867A1 Pyrrolo [2, 3-d] pyrimidines as inhibitors of hsp90
04/22/2010WO2010043847A1 Medium derived from stem cells as a pharmaceutical composition
04/22/2010WO2010043696A1 Composition comprising a combination of an elder extract and a strain of l. paracasei, l. casei, l. bulgaricus or s. thermophilus
04/22/2010WO2010043675A1 Pharmaceutical product for up-dosing of allergy vaccine
04/22/2010WO2010043633A1 2h-pyrazolo [4,3-d]pyrimidin-5-amine derivatives as h4 histamine receptor antagonists for the treatment of allergic, immunological and inflammatory diseases
04/22/2010WO2010043230A1 Multiligand constructs
04/22/2010WO2010043039A1 Combination adjuvant formulation
04/22/2010WO2010043000A1 S1p receptors modulators and their use thereof
04/22/2010WO2010042998A1 S1p receptors modulators
04/22/2010WO2010003002A3 Modulation of follicular helper t cells
04/22/2010WO2009107098A3 An oral treatment composition comprising potassium nitrate and hexylene glycol
04/22/2010WO2009043450A8 Use of neurotrophic factor for retinal cholinergic neurons (nfrcn) and chorionic gonadotropin-beta (109-145) as therapeutic agents
04/22/2010US20100099742 Sensitizing Cells for Apoptosis by Selectively Blocking Cytokines
04/22/2010US20100099729 Nitric oxide donor compounds
04/22/2010US20100099689 Methods of modulating ppar gamma-type receptors
04/22/2010US20100099680 Pteridinone derivatives as p13-kinases inhibitors
04/22/2010US20100099673 Decahydroquinoline analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
04/22/2010US20100099659 Inhibitors of Bruton's Tyrosine Kinase
04/22/2010US20100099642 Tgf-beta stimulant and further agent to reduce side effects
04/22/2010US20100099618 Interleukin-9 and Interleukin-4 Chimeric Antagonist Muteins and Methods of Using Same
04/22/2010US20100099617 Secreted proteins
04/22/2010US20100099613 Peptides for inducing a ctl and/or htl response to hepatitis c virus
04/22/2010US20100099606 Effective use method of medicaments and method of preventing expression of side effect
04/22/2010US20100099605 Chaperonin 10 immunosuppression
04/22/2010US20100098784 Capsule containing plant preparations
04/22/2010US20100098770 Sirolimus pharmaceutical formulations
04/22/2010US20100098729 Novel surface exposed immunoglobulin d-binding protein from foraxella catarrhalis
04/22/2010US20100098725 Methods for cultivating cells, propagating and purifying viruses
04/22/2010US20100098722 Packaging of Immunostimulatory Substances Into Virus-Like Particles: Method of Preparation and Use
04/22/2010US20100098715 Annexin ii compositions for treating or monitoring inflammation or immune-mediated disorders
04/22/2010US20100098712 Pharmaceutical formulation of an antibody against OX40L
04/22/2010US20100098709 Antibodies Specific For The Complex Of Interleukin-6 And The Interleukin-6 Receptor
04/22/2010US20100098688 Method for diagnosis of a disease involving an anti-at1-receptor antibody
04/22/2010US20100098686 Method for reducing levels of C-reactive protein
04/22/2010US20100098684 Biomarkers and methods for detecting and treating spinal and joint pain
04/22/2010US20100098680 Anti-pathogen treatments
04/22/2010DE202004021680U1 Feste pharmazeutische Zusammensetzung A solid pharmaceutical composition
04/22/2010CA2740560A1 Composition comprising a combination of an elder extract and a strain of l. paracasei, l. casei, l. bulgaricus or s. thermophilus
04/22/2010CA2740554A1 Multiligand constructs
04/22/2010CA2740484A1 S1p receptors modulators and their use thereof
04/22/2010CA2739901A1 S1p receptors modulators
04/22/2010CA2739557A1 Pharmaceutical product for up-dosing of allergy vaccine
04/22/2010CA2737352A1 Combination adjuvant formulation
04/22/2010CA2725383A1 Smallpox dna vaccine and the antigens therein that elicit an immune response
04/21/2010EP2177619A1 HSV strains for the oncolytic treatment of cancer
04/21/2010EP2177616A1 Soluble zcytor 11 cytokine receptors
04/21/2010EP2177537A2 Antibodies to MAdCAM
04/21/2010EP2177530A1 Octapeptide having antiangiogenic activity
04/21/2010EP2177517A1 Amino substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimide for reducing TNF alpha levels
04/21/2010EP2177230A1 Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor
04/21/2010EP2177229A2 Functional composition or food comprising whey protein, antibody derived from milk or antibody
04/21/2010EP2177228A1 DNA vaccination for treatment of autoimmune disease
04/21/2010EP2175856A2 Novel process for preparing highly pure levocetirizine and salts thereof
04/21/2010EP1761494B1 Chemical compounds i
04/21/2010EP1610780B1 Cyclic protein tyrosine kinase inhibitors
04/21/2010EP1479670B1 Novel fused ring indazole compounds
04/21/2010EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists
04/21/2010EP1231930B1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS
04/21/2010EP0888303B1 Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
04/21/2010CN1973885B Shenjing capsule and shenjing oral liquid
04/21/2010CN1891267B Chinese medicine for treating atrophic arthritis
04/21/2010CN1823604B Seaweed tea and its preparation method
04/21/2010CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors
04/21/2010CN1689628B Medical purpose of creat extract
04/21/2010CN101696243A Human genetic engineering antibody TRD 109 as well as preparation method and application thereof
04/21/2010CN101696205A 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition
04/21/2010CN101696183A (Z)-2-phenyl-3-(pyrrol-2-yl)-acrylonitrile derivative as well as salts, composition, preparation method and application thereof
04/21/2010CN101695518A Method for extracting total alkaloid of common fibraurea stems, separate fibriuretinin and jatrorrhizine
04/21/2010CN101695516A Immunostimulant for aquatic animals and preparation method thereof
04/21/2010CN101695497A Injection medicament for treating chronic lymphoid thyreoitis
04/21/2010CN101695480A Olopatadine hydrochloride dispersible tablets, preparation method thereof and quality control method thereof
04/21/2010CN101695374A Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
04/21/2010CN101181290B Pharmaceutical composition and preparation method thereof
04/21/2010CN101172161B Water-soluble polymers decorated G-CSF conjugates
04/21/2010CN101099798B Life prolonging health care product and its preparation method
04/21/2010CN101062950B Polyethylene glycol modified thymus peptide 1 derivative
04/20/2010US7700758 Preparing library of heterogenous small interfering RNA sequences (HSIRNA) for use in gene expression inhibition and mammalian therapeutics; gene therapy
04/20/2010US7700719 Mutant protofibril for active immunisation; synuclein genes, proteins; point mutations; Parkinson's disease; dementia; host cells
04/20/2010US7700657 Vitamin D analogs
1 ... 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 ... 1172